Study Evaluating AMG 706 in Subjects With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

71

Participants

Timeline

Start Date

July 31, 2003

Primary Completion Date

February 28, 2006

Study Completion Date

December 31, 2006

Conditions
Tumors
Interventions
DRUG

Anti-angiogenesis

Anti-angiogenesis

DRUG

AMG 706

Anti-angiogenesis

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Amgen

INDUSTRY